Chemical and Pharmaceutical Bulletin
Online ISSN : 1347-5223
Print ISSN : 0009-2363
ISSN-L : 0009-2363
Regular Articles
Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors IV.
A Series of New Derivatives Containing a Spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4′-piperidin]-5-one Skeleton
Hidemitsu Nishida, Takafumi Mukaihira, Fumihiko Saitoh, Kousuke Harada, Miyuki Fukui, Tomokazu Matsusue, Atsushi Okamoto, Yoshitaka Hosaka, Miwa Matsumoto, Ikuya Shiromizu, Shuhei Ohnishi, Hidenori Mochizuki
Author information
JOURNAL FREE ACCESS

2004 Volume 52 Issue 4 Pages 406-412

Details
Abstract
In the course of development of factor Xa (FXa) inhibitor in an investigation involving the synthesis of 1-arylsulfonyl-3-piperazinone derivatives, we found new compounds containing a unique spiro skeleton. Among such compounds, (−)-7-[(6-chloro-2-naphthalenyl)sulfonyl]tetrahydro-8a-(methoxymethyl)-1′-(4-pyridinyl)-spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4′-piperidin]-5-one (28, M55529) had activity more favorable than those of previously reported compounds. The inhibitory activity of M55529 for FXa is IC50=2 nM, with high selectivity for FXa over thrombin and trypsin.
Content from these authors
© 2004 The Pharmaceutical Society of Japan
Previous article Next article
feedback
Top